UBS: Eli Lilly's 'Outlook Continuing To Improve' By: Benzinga via Benzinga February 02, 2015 at 10:25 AM EST UBS on Monday issued a report on Eli Lilly and Co (NYSE: LLY). The firm rates Eli Lilly as Neutral with a one-year price target of ... Read More >> Related Stocks: Eli Lilly